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Introduction 
Microgravity exposure may alter the likelihood that astronauts will experience 
renal stones.  The potential risk includes both acute and chronic health issues, 
with the potential for significant impact on mission objectives. 
 
Methods 
To understand the role of the NASA’s Human Research Program (HRP) research 
agenda in both preventing and addressing renal stones in spaceflight, current 
astronaut epidemiologic data and a summary of programmatic considerations are 
reviewed.   
 
Results 
Although there has never been a symptomatic renal stone event in a U.S. 
crewmember during spaceflight, urine chemistry has been altered – likely due to 
induced changes in renal physiology as a result of exposure to microgravity.  
This may predispose astronauts to stone formation, leading the HRP to conduct 
and sponsor research to: 1) understand the risk of stone formation in space; 2) 
prevent stones from forming; and 3) address stones that may form by providing 
novel diagnostic and therapeutic approaches.   
 
 
Discussion 
The development of a renal stone during spaceflight is a significant medical 
concern that requires the HRP to minimize this risk by providing the ability to 
prevent, diagnose, monitor and treat the condition during spaceflight.  A 
discussion of the risk as NASA understands it is followed by an overview of the 
multiple mitigations currently under study, including novel ultrasound techniques 
for stone detection and manipulation, and how they may function as part of a 
larger exploration medical system. 
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